EP1078989B1 - Method for producing L-glutamic acid by fermentation accompanied by precipitation - Google Patents

Method for producing L-glutamic acid by fermentation accompanied by precipitation Download PDF

Info

Publication number
EP1078989B1
EP1078989B1 EP00117807A EP00117807A EP1078989B1 EP 1078989 B1 EP1078989 B1 EP 1078989B1 EP 00117807 A EP00117807 A EP 00117807A EP 00117807 A EP00117807 A EP 00117807A EP 1078989 B1 EP1078989 B1 EP 1078989B1
Authority
EP
European Patent Office
Prior art keywords
glutamic acid
microorganism
strain
gene
carbon source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP00117807A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1078989A2 (en
EP1078989A3 (en
EP1078989A8 (en
Inventor
Hiroshi c/o Ajinomoto Co. Inc. Izui
Mika c/o Ajinomoto Co. Inc. Moriya
Seiko c/o Ajinomoto Co. Inc. Hirano
Yoshihiko c/o Ajinomoto Co. Inc. Hara
Hisao c/o Ajinomoto Co. Inc. ITO
Kazuhiko c/o Zao Agri Matsui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of EP1078989A2 publication Critical patent/EP1078989A2/en
Publication of EP1078989A8 publication Critical patent/EP1078989A8/en
Publication of EP1078989A3 publication Critical patent/EP1078989A3/en
Application granted granted Critical
Publication of EP1078989B1 publication Critical patent/EP1078989B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C12N9/0016—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with NAD or NADP as acceptor (1.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C12P13/14—Glutamic acid; Glutamine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Definitions

  • the present invention relates to a method for producing L-glutamic acid by fermentation accompanied by precipitation.
  • L-Glutamic acid is widely used as a material of seasonings and so forth.
  • L-Glutamic acid is mainly produced by fermentative methods using so-called coryneform bacteria producing L-glutamic acid and belonging to the genus Brevibacterium , Corynebacterium or Microbacterium , or mutant strains thereof (Amino Acid Fermentation, pp.195-215, Gakkai Shuppan Center, 1986).
  • methods for producing L-glutamic acid by fermentation by using other bacterial strains there are known a method using a microorganism belonging to the genus Bacillus , Streptomyces , Penicillium or the like (U.S. Patent No.
  • the inventors of the present invention have proposed a method for producing L-glutamic acid by using a microorganism belonging to the genus Klebsiella , Erwinia or Pantoea (Japanese Patent Application Laid-open No. 2000-106869).
  • Japanese Patent Application Laid-open No. 63-214189 discloses a technique for improving L-glutamic acid-producing ability by amplifying a glutamate dehydrogenase gene, an isocitrate dehydrogenase gene, an aconitate hydratase gene and a citrate synthase gene.
  • L-glutamic acid productivity has been considerably increased by breeding of the aforementioned microorganisms or improvement of production methods, development of methods for more efficiently producing L-glutamic acid at a lower cost is required to respond to further increase of the demand in future.
  • amino acids suitable for this method are those of relatively low water solubility, and no example of applying the method to highly water-soluble amino acids such as L-glutamic acid is known.
  • the medium must have low pH to precipitate L-glutamic acid.
  • L-glutamic acid-producing bacteria such as those mentioned above cannot grow under acidic conditions, and therefore L-glutamic acid fermentation is performed under neutral conditions (U.S. Patent Nos. 3,220,929 and 3,032,474; Chao K.C. & Foster J.W., J. Bacteriol., 77, pp.715-725 (1959)).
  • L-glutamic acid by fermentation accompanied by precipitation is not known. Furthermore, it is known that growth of most acidophile bacteria is inhibited by organic acids such as acetic acid, lactic acid and succinic acid (Yasuro Oshima Ed., "Extreme Environment Microorganism Handbook", p.231, Science Forum; Borichewski R.M., J. Bacteriol., 93, pp.597-599 (1967) etc.). Therefore, it is considered that many microorganisms are susceptible to L-glutamic acid, which is also an organic acid, under acidic conditions, and there has been no report that search of microorganisms showing L-glutamic acid-producing ability under acidic conditions was attempted.
  • organic acids such as acetic acid, lactic acid and succinic acid
  • an object of the present invention is to search and breed a microorganism that produces L-glutamic acid under low pH conditions and to provide a method for producing L-glutamic acid using an obtained microorganism by fermentation with precipitating L-glutamic acid.
  • the inventors of the present invention considered during the study for improvement of L-glutamic acid productivity by fermentation that inhibition of the production by L-glutamic acid accumulated in a medium at a high concentration was one of obstructions to the improvement of productivity.
  • cells have an excretory system and an uptake system for L-glutamic acid.
  • L-glutamic acid once excreted into the medium is incorporated into cells again, not only the production efficiency falls, but also the L-glutamic acid biosynthetic reactions are inhibited as a result.
  • the inventors of the present invention screened microorganisms that can proliferate under acidic conditions and in the presence of a high concentration of L-glutamic acid. As a result, they successfully isolated microorganisms having such properties from a soil, and thus accomplished the present invention.
  • the present invention provides the following.
  • L-glutamic acid can be produced by fermentation with precipitating L-glutamic acid.
  • L-glutamic acid in the medium is maintained below a certain concentration, and L-glutamic acid can be produced without suffering from the product inhibition by L-glutamic acid at a high concentration.
  • the microorganism used in the method of the present invention is a microorg sm that (1) can metabolize a carbon source at a pH of 3.0 to 5.0 in a liquid medium containing L-glutamic acid at a saturation concentration and the carbon source and (2) has ability to accumulate L-glutamic acid in an amount exceeding the amount corresponding to the saturation concentration in the liquid medium at the pH.
  • saturation concentration means a concentration of L-glutamic acid dissolved in a liquid medium when the liquid medium is saturated with L-glutamic acid.
  • a sample containing microorganisms is inoculated into a liquid medium containing L-glutamic acid at a saturation concentration and a carbon source at a pH of 3.0 to 5.0, and a strain that can metabolize the carbon source is selected.
  • the microorganism of is used to produce L-glutamic acid by fermentation with precipitating L-glutamic acid. If the pH is too high, it becomes difficult to allow the microorganism to produce L-glutamic acid enough for precipitation. Therefore, pH is in the aforementioned range.
  • L-glutamic acid is usually dissolved in an amount of 10 to 20 g/L at pH 3.2, 30 to 40 g/L at pH 4.0 and 50 to 60 g/L at pH 4.7, at about 30°C.
  • the pH is not made below 3.0, because the L-glutamic acid precipitating effect plateaus when pH goes below a certain value.
  • a microorganism proliferates when cultured in a liquid medium containing L-glutamic acid at a saturation concentration at pH 5.0 to 4.0, preferably pH 4.5 to 4.0, more preferably pH 4.3 to 4.0, still more preferably pH 4.0 at an appropriate temperature, for example, 28°C, 37°C or 50°C for 2 to 4 days, this microorganism can metabolize the carbon source in the medium.
  • the microorganism which consumes the carbon source in the medium is that can metabolize the carbon source in the medium.
  • the microorganism which can metabolize the carbon source includes a microorganism which can grow in the liquid medium.
  • a microorganism can grow in the medium.
  • a microorganism proliferates when cultured in a liquid medium containing L-glutamic acid at a saturation concentration at pH 5.0 to 4.0, preferably pH 4.5 to 4.0, more preferably pH 4.3 to 4.0, still more preferably pH 4.0 at an appropriate temperature, for example, 28°C, 37°C or 50°C for 2 to 4 days, this microorganism can grow in the medium.
  • the microorganism which increases the amount of L-glutamic acid in the medium is that can grow in the medium.
  • the selection described above may be repeated two or more times under the same conditions or with changing pH or the concentration of L-glutamic acid.
  • An initial selection can be performed in a medium containing L-glutamic acid at a concentration lower than the saturation concentration, and thereafter a subsequent selection can be performed in a medium containing L-glutamic acid at a saturation concentration. Further, strains with favorable properties such as superior proliferation rate may be selected.
  • the microorganism used in the method of the present invention has ability to accumulate L-glutamic acid in an amount exceeding the amount corresponding to the saturation concentration of L-glutamic acid in a liquid medium.
  • the pH of the aforementioned liquid medium is preferably the same as or close to that of the medium used for screening a microorganism having the aforementioned property (1).
  • a microorganism becomes susceptible to L-glutamic acid at a high concentration as pH becomes lower. Therefore, it is preferred that pH is not low from the viewpoint of resistance to L-glutamic acid, but low pH is preferred from the viewpoint of production of L-glutamic acid with precipitating it.
  • pH is in the range of 3 to 5, preferably 4 to 5, more preferably 4.0 to 4.7, still more preferably 4.0 to 4.5, particularly preferably 4.0 to 4.3.
  • microorganisms belonging to the genus Enterobacter Klebsiella , Serratia , Pantoea , Erwinia, Escherichia , Corynebacterium , Alicyclobacillus , Bacillus , Saccharomyces or the like.
  • microorganisms belonging to the genus Enterobacter are preferred.
  • the microorganism of the present invention will be explained mainly for microorganisms belonging to the genus Enterobacter , but the present invention can be applied to microorganism belonging to other genera and not limited to the genus Enterobacter .
  • Enterobacter agglomerans As microorganisms belonging to the Enterobacter , there can be specifically mentioned Enterobacter agglomerans , preferably the Enterobacter agglomerans AJ13355 strain. This strain was isolated from a soil in Iwata-shi, Shizuoka, Japan as a strain that can proliferate in a medium containing L-glutamic acid and a carbon source at low pH.
  • AJ13355 was determined as Enterobacter agglomerans .
  • the Enterobacter agglomerans AJ13355 was deposited at the National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry (postal code: 305-8566, 1-3, Higashi 1-chome, Tsukuba-shi, Ibaraki, Japan) on February 19, 1998 and received an accession number of FERM P-16644. It was then transferred to an international deposition under the provisions of Budapest Treaty on January 11, 1999 and received an accession number of FERM BP-6614.
  • the microorganism used in the method of the present invention may be a microorganism originally having L-glutamic acid-producing ability or one having L-glutamic acid-producing ability imparted or enhanced by breeding through use of mutation treatment, recombinant DNA techniques or the like.
  • L-Glutamic acid-producing ability can be imparted or enhanced by, for example, increasing activity of an enzyme that catalyzes a reaction for biosynthesis of L-glutamic acid.
  • L-Glutamic acid-producing ability can also be enhanced by decreasing activity of an enzyme that catalyzes a reaction branching from the biosynthetic pathway of L-glutamic acid and producing a compound other than L-glutamic acid, or making the activity deficient.
  • glutamate dehydrogenase (hereafter, also referred to as "GDH”), glutamine synthetase, glutamate synthase, isocitrate dehydrogenase, aconitate hydratase, citrate synthase (hereafter, also referred to as "CS"), phosphoenolpyruvate carboxylase (hereafter, also referred to as "PEPC”), pyruvate dehydrogenase, pyruvate kinase, enolase, phosphoglyceromutase, phosphoglycerate kinase, glyceraldehyde-3-phosphate dehydrogenase, triosephosphate isomerase, fructose bisphosphate aldolase, phosphofructokinase, glucose phosphate isomerase and so forth.
  • GDH glutamate dehydrogenase
  • CS citrate synthase
  • PEPC phosphoeno
  • CS CS of Brevibacterium lactofermentum
  • CS of Brevibacterium lactofermentum
  • a gene coding for CS, PEPC or GDH may be cloned on an appropriate plasmid and a host microorganism may be transformed with the obtained plasmid.
  • the copy number of the gene coding for CS, PEPC or GDH (hereafter, abbreviated as " gltA gene”, “ ppc gene” and " gdhA gene”, respectively) in the transformed strain cell increases, resulting in the increase of the activity of CS, PEPC or GDH.
  • the cloned gltA gene, ppc gene and gdhA gene are introduced into the aforementioned starting parent strain solely or in combination of arbitrary two or three kinds of them.
  • two or three kinds of the genes may be cloned on one kind of plasmid and introduced into the host, or separately cloned on two or three kinds of plasmids that can coexist and introduced into the host.
  • Two or more kinds of genes coding for enzymes of the same kind, but derived from different microorganisms may be introduced into the same host.
  • the plasmids described above are not particularly limited so long as they are autonomously replicable in cells of a microorganism belonging to, for example, the genus Enterobacter or the like, but, for example, there can be mentioned pUC19, pUC18, pBR322, pHSG299, pHSG298, pHSG399, pH SG398, RSF1010, pMW119, pMW118, pMW219, pMW218, pACYC177, pACYC184 and so forth. Besides these, vectors of phage DNA can also be used.
  • Transformation can be performed by, for example, the method of D.M. Morrison (Methods in Enzymology, 68, 326 (1979)), the method wherein permeability of DNA is increased by treating recipient bacterium cells with calcium chloride (Mandel M. and Higa A., J. Mol. Biol., 53, 159 (1970)), the electroporation (Miller J.H., "A Short Course in Bacterial Genetics", Cold Spring Harbor Laboratory Press, U.S.A. 1992) or the like.
  • the activity of CS, PEPC or GDH can also be increased by allowing multiple copies of a gltA gene, a ppc gene or a gdhA gene to be present on chromosomal DNA of the aforementioned starting parent strain to be a host.
  • a sequence of which multiple copies are present on the chromosomal DNA such as repetitive DNA and inverted repeats present at termini of a transposable element, can be used.
  • multiple copies of the genes can be introduced onto chromosomal DNA by utilizing transfer of a transposon containing the gltA gene, the ppc gene or the gdhA gene.
  • the copy number of the gltA gene, the ppc gene or the gdhA gene in a transformed strain cell is increased, and thus the activity of CS, PEPC or GDH is increased.
  • any organism can be used so long as it has activity of CS, PEPC or GDH.
  • bacteria which are prokaryotes, for example, those belonging to the genus Enterobacter , Klebsiella , Erwinia, Pantoea, Serratia, Escherichia, Corynebacterium , Brevibacterium and Bacillus are preferred.
  • Escherichia coli a source of the gltA gene
  • the ppc gene and the gdhA gene can be obtained from chromosomal DNA of the microorganisms described above.
  • the gltA gene, the ppc gene and the gdhA gene can be obtained by using a mutant strain which is deficient in the activity of CS, PEPC or GDH to isolate a DNA fragment which complements the auxotrophy from chromosomal DNA of the aforementioned microorganisms. Since the nucleotide sequences of these genes of Escherichia and Corynebacterium bacteria have already been elucidated (Biochemistry, 22, pp.5243-5249 (1983); J. Biochem., 95, pp.909-916 (1984); Gene, 27, pp.193-199 (1984); Microbiology, 140, pp.1817-1828 (1994); Mol. Gen.
  • the activity of CS, PEPC or GDH can also be increased by enhancing the expression of the gltA gene, the ppc gene or the gdhA gene besides the aforementioned amplification of the genes.
  • the expression can be enhanced by replacing a promoter for the gltA gene, the ppc gene or the gdhA gene with other stronger promoters.
  • lac promoter, trp promoter, trc promoter, tac promoter, P R promoter and P L promoter of the lamda phage and so forth are known as strong promoters.
  • the gltA gene, the ppc gene and the gdhA gene of which promoter is replaced are cloned on a plasmid and introduced into the host microorganism, or introduced onto the chromosomal DNA of the host microorganism by using repetitive DNA, inverted repeats, transposon or the like.
  • the activity of CS, PEPC or GDH can also be enhanced by replacing the promoter of the gltA gene, the ppc gene or the gdhA gene on the chromosome with other stronger promoters (see WO 87/03006 and Japanese Patent Application Laid-open No. 61-268183), or inserting a strong promoter in the upstream of the coding sequence of each gene (see Gene, 29, pp.231-241 (1984)).
  • homologous recombination can be performed between DNA containing the gltA gene, the ppc gene or the gdhA gene of which promoter is replaced with a stronger one or a part thereof and the corresponding gene on the chromosome.
  • Examples of the enzyme which catalyze a reaction branching from the biosynthetic pathway of the L-glutamic acid and producing a compound other than L-glutamic acid include ⁇ -ketoglutarate dehydrogenase (hereafter, also referred to as " ⁇ KGDH”), isocitrate lyase, phosphate acetyltransferase, acetate kinase, acetohydroxy acid synthase, acetolactate synthase, formate acetyltransferase, lactate dehydrogenase, glutamate decarboxylase, 1-pyrroline dehydrogenase and so forth.
  • ⁇ KGDH is preferred.
  • mutation causing decrease or deficiency of the intracellular activity of the enzyme can be introduced into the gene of the aforementioned enzyme by a usual mutagenesis or genetic engineering method.
  • mutagenesis method examples include, for example, methods utilizing irradiation with X-ray or ultraviolet ray, methods utilizing treatment with a mutagenic agent such as N-methyl-N'-nitro-N-nitrosoguanidine, and so forth.
  • the site where the mutation is introduced to the gene may be in a coding region coding for an enzyme protein, or a region for regulating expression such as a promoter.
  • Examples of the genetic engineering methods include, for example, methods utilizing gene recombination, transduction, cell fusion and so forth.
  • a drug resistance gene is inserted into a cloned target gene to prepare a gene that has lost its function (defective gene).
  • this defective gene is introduced into a cell of a host microorganism, and the target gene on the chromosome is replaced with the aforementioned defective gene by utilizing homologous recombination (gene disruption).
  • Decrease or deficiency of intracellular activity of the target enzyme and the degree of decrease of the activity can be determined by measuring the enzyme activity of a cell extract or a purified fraction thereof obtained from a candidate strain and comparing with that of a wild strain.
  • the ⁇ KGDH activity can be measured by the method of Reed et al. (Reed L.J. and Mukherjee B.B., Methods in Enzymology, 13, pp.55-61 (1969)).
  • the target mutant strain can be selected based on the phenotype of the mutant strain. For example, a mutant strain which is deficient in the ⁇ KGDH activity or decreases in the ⁇ KGDH activity cannot proliferate or shows a markedly reduced proliferation rate in a minimal medium containing glucose or a minimal medium containing acetic acid or L-glutamic acid as an exclusive carbon source under aerobic conditions. However, normal proliferation is enabled even under the same condition by adding succinic acid or lysine, methionine and diaminopimelic acid to a minimal medium containing glucose. By utilizing these phenomena as indicators, mutant strains with decreased ⁇ KGDH activity or deficient in the activity can be selected.
  • Enterobacter agglomerans AJ13356 As a specific example of a mutant strain deficient in ⁇ KGDH activity or with decreased ⁇ KGDH activity obtained as described above, there can be mentioned Enterobacter agglomerans AJ13356.
  • Enterobacter agglomerans AJ13356 was deposited at the National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry (postal code: 305-8566, 1-3, Higashi 1-chome, Tsukuba-shi, Ibaraki, Japan) on February 19, 1998 and received an accession number of FERM P-16645. It was then transferred to an international deposition under the provisions of Budapest Treaty on January 11, 1999 and received an accession number of FERM BP-6615.
  • the Enterobacter agglomerans AJ13356 is deficient in ⁇ KGDH activity as a result of disruption of the ⁇ KGDH-E1 subunit gene (sucA).
  • Enterobacter agglomerans an example of the microorganism used in the present invention, is cultured in a medium containing a saccharide, a viscous material is extracellularly secreted, resulting in low operation efficiency. Therefore, when Enterobacter agglomerans having such a property of secreting the viscous material is used, it is preferable to use a mutant strain that secretes less the viscous material compared with a wild strain.
  • mutagenesis methods include, for example, methods utilizing irradiation with X ray or ultraviolet ray, method utilizing treatment with a mutagenic agent such as N-methyl-N'-nitro-N-nitrosoguanidine and so forth.
  • a mutant strain with decreased secretion of the viscous material can be selected by inoculating mutagenized bacterial cells in a medium containing a saccharide, for example, LB medium plate containing 5 g/L of glucose, culturing them with tilting the plate about 45 degrees and selecting a colony which does not show flowing down of liquid.
  • a medium containing a saccharide for example, LB medium plate containing 5 g/L of glucose
  • impartation or enhancement of L-glutamic acid-producing ability and impartation of other favorable properties such as mutation for less viscous material secretion described above can be carried out in an arbitrary order.
  • L-glutamic acid By culturing the microorganism used in the method of the present invention in a liquid medium of which pH is adjusted to a pH at which L-glutamic acid is precipitated, L-glutamic acid can be produced and accumulated with precipitating it in the medium. L-Glutamic acid can also be precipitated by starting the culture at a neutral pH and then ending it at a pH at which L-glutamic acid is precipitated.
  • the pH at which L-glutamic acid is precipitated means one at which L-glutamic acid is precipitated when the microorganism produces and accumulates L-glutamic acid.
  • a usual nutrient medium containing a carbon source, a nitrogen source, mineral salts and organic trace nutrients such as amino acids and vitamins as required can be used so long as pH is adjusted to a pH at which L-glutamic acid is precipitated.
  • a synthetic medium or a natural medium can be used.
  • the carbon source and the nitrogen source used in the medium can be any ones so long as they can be used by the cultured strain.
  • carbon source saccharides such as glucose, glycerol, fructose, sucrose, maltose, mannose, galactose, starch hydrolysate and molasses are used.
  • organic acids such as acetic acid and citric acid may be used each alone or in combination with another carbon source.
  • ammonia As the nitrogen source, ammonia, ammonium salts such as ammonium sulfate, ammonium carbonate, ammonium chloride, ammonium phosphate and ammonium acetate, nitrates and so forth are used.
  • organic trace nutrients amino acids, vitamins, fatty acids, nucleic acids, those containing these substances such as peptone, casamino acid, yeast extract and soybean protein decomposition products are used.
  • an auxotrophic mutant strain that requires an amino acid and so forth for metabolization or growth is used, the required nutrient must be supplemented.
  • mineral salts phosphates, magnesium salts, calcium salts, iron salts, manganese salts and so forth are used.
  • aeration culture is usually performed with controlling the fermentation temperature to be 20 to 42°C and pH to be 3 to 5, preferably 4 to 5, more preferably 4 to 4.7, particularly preferably 4 to 4.5.
  • the fermentation temperature to be 20 to 42°C and pH to be 3 to 5, preferably 4 to 5, more preferably 4 to 4.7, particularly preferably 4 to 4.5.
  • L-glutamic acid precipitated in the culture can be collected by centrifugation, filtration or the like.
  • L-Glutamic acid dissolved in the medium can be collected according to known methods.
  • the L-glutamic acid can be isolated by concentrating the culture broth to crystallize it or isolated by ion exchange chromatography or the like.
  • L-Glutamic acid precipitated in the culture broth may be isolated together with L-glutamic acid that have been dissolved in the medium after it is crystallized.
  • L-glutamic acid exceeding the amount corresponding to the saturation concentration is precipitated, and the concentration of L-glutamic acid dissolved in the medium is maintained at a constant level. Therefore, influence of L-glutamic acid at a high concentration on microorganisms can be reduced. Accordingly, it becomes possible to breed a microorganism having further improved L-glutamic acid-producing ability. Further, since L-glutamic acid is precipitated as crystals, acidification of the culture broth by accumulation of L-glutamic acid is suppressed, and therefore the amount of alkali used for maintaining pH of the culture can significantly be reduced.
  • Screening of a microorganism having L-glutamic acid resistance in an acidic environment was performed as follows. Each of about 500 samples obtained from nature including soil, fruits, plant bodies, river water in an amount of 1 g was suspended in 5 mL of sterilized water, of which 200 ⁇ L was coated on 20 mL of solid medium of which pH was adjusted to 4.0 with HCl.
  • composition of the medium was as follows: 3 g/L of glucose, 1 g/L of (NH 4 ) 2 SO 4 , 0.2 g/L of MgSO 4 ⁇ 7H 2 O, 0.5 g/L of KH 2 PO 4 , 0.2 g/L of NaCl, 0.1 g/L of CaCl 2 ⁇ 7H 2 O, 0.01 g/L of FeSO 4 ⁇ 7H 2 O, 0.01 g/L of MnSO 4 ⁇ 4H 2 O, 0.72 mg/L of ZnSO 4 ⁇ 2H 2 O, 0.64 mg/L of CuSO 4 ⁇ 5H 2 O, 0.72 mg/L of CoCl 2 ⁇ 6H 2 O, 0.4 mg/L of boric acid, 1.2 mg/L of Na 2 MoO 4 ⁇ 2H 2 O, 50 ⁇ g/L of biotin, 50 ⁇ g/L of calcium pantothenate, 50 ⁇ g/L of folic acid, 50 ⁇ g/L of inosi
  • the media plated on which the above samples were plated were incubated at 28°C, 37°C or 50°C for 2 to 4 days and 378 strains each forming a colony were obtained.
  • each of the strains obtained as described above was inoculated in a test tube of 16.5 cm in length and 14 mm in diameter containing 3 mL of liquid medium (adjusted to pH 4.0 with HCl) containing a saturation concentration of L-glutamic acid and cultured at 28°C, 37°C or 50°C for 24 hours to 3 days with shaking. Then, the grown strains were selected.
  • composition of the aforementioned medium was follows: 40 g/L of glucose, 20 g/L of (NH 4 ) 2 SO 4 , 0.5 g/L of MgSO 4 ⁇ 7H 2 O, 2 g/L of KH 2 PO 4 , 0.5 g/L of NaCl, 0.25 g/L of CaCl 2 ⁇ 7H 2 O, 0.02 g/L of FeSO 4 ⁇ 7H 2 O, 0.02 g/L of MnSO 4 ⁇ 4H 2 O, 0.72 mg/L of ZnSO 4 ⁇ 2H 2 O, 0.64 mg/L of CuSO 4 ⁇ 5H 2 O, 0.72 mg/L of CoCl 2 ⁇ 6H 2 O, 0.4 mg/L of boric acid, 1.2 mg/L of Na 2 MoO 4 ⁇ 2H 2 O, 2 g/L of yeast extract.
  • the various microorganisms having L-glutamic acid resistance in an acidic environment obtained as described above were each inoculated into a test tube of 16.5 cm in length and 14 mm in diameter containing 3 mL of medium (adjusted to pH 4.0 with HCl) obtained by adding 20 g/L of glutamic acid and 2 g/L of glucose to M9 medium (Sambrook, J., Fritsh, E.F. and Maniatis, T., "Molecular Cloning", Cold Spring Harbor Laboratory Press, 1989), and the turbidity of the medium was measured in the time course to select strains with a favorable growth rate.
  • the AJ13355 strain was obtained from a soil in Iwata-shi, Shizuoka, Japan. This strain was determined as Enterobacter agglomerans based on its bacteriological properties described above.
  • the Enterobacter agglomerans AJ13355 strain was irradiated with ultraviolet ray for 2 minutes at the position 60 cm away from a 60-W ultraviolet lamp and cultured in LB medium overnight to fix mutation.
  • the mutagenized strain was diluted and inoculated in LB medium containing 5 g/L of glucose and 20 g/L of agar so that about 100 colonies per plate would emerge and cultured at 30°C overnight with tilting the plate about 45 degrees, and then 20 colonies showing no flowing down of the viscous material were selected.
  • a strain deficient in ⁇ KGDH and with enhanced L-glutamic acid biosynthetic system was prepared from the Enterobacter agglomerans SC17 strain.
  • sucAB Cloning of ⁇ KGDH gene (hereafter, referred to as " sucAB ”) of Enterobacter agglomerans AJ13355 strain
  • sucAB gene of the Enterobacter agglomerans AJ13355 strain was cloned by selecting a DNA fragment complementing the acetic acid-unassimilating property of the ⁇ KGDH-E1 subunit gene (hereafter, referred to as " sucA ”) deficient strain of Escherichia coli from chromosomal DNA of the Enterobacter agglomerans AJ13355 strain.
  • the chromosomal DNA of the Enterobacter agglomerans AJ13355 strain was isolated by a method usually employed when chromosomal DNA is extracted from Escherichia coli (Text for Bioengineering Experiments, Edited by the Society for Bioscience and Bioengineering, Japan, pp.97-98, Baifukan, 1992).
  • the pTWV228 (resistant to ampicillin) used as a vector was commercially available one from Takara Shuzo Co., Ltd.
  • the chromosomal DNA of the AJ13355 strain digested with EcoT221 and pTWV228 digested with PstI were ligated by using T4 ligase and used to transform the sucA deficient Escherichia coli JRG465 strain (Herbert, J. et al., Mol. Gen. Genetics, 105, 182 (1969)).
  • a strain growing in an acetate minimal medium was selected from the transformant strains obtained above, and a plasmid was extracted from it and designated as pTWVEK101.
  • the Escherichia coli JRG465 strain harboring pTWVEK101 recovered auxotrophy for succinic acid or L-lysine and L-methionine besides the acetic acid-assimilating property. This suggests that pTWVEK101 contains the sucA gene of Enterobacter agglomerans .
  • Fig. 1 shows the restriction map of a DNA fragment derived from Enterobacter agglomerans in pTWVEK101.
  • the determined nucleotide sequence of the hatched portion in Fig. 1 is shown as SEQ ID NO: 1.
  • SEQ ID NOS: 2 to 5 show amino acid sequences that can be encoded by these ORFs or partial sequences in an order from the 5' end.
  • nucleotide sequences contained a 3'-end partial sequence of the succinate dehydrogenase iron-sulfur protein gene ( sdhB ), full length sucA and ⁇ KGDH-E2 subunit gene ( sucB ), and 5'-end partial sequence of the succinyl CoA synthetase ⁇ subunit gene ( sucC ).
  • sdhB succinate dehydrogenase iron-sulfur protein gene
  • sucB full length sucA and ⁇ KGDH-E2 subunit gene
  • sucC succinyl CoA synthetase ⁇ subunit gene
  • the homologous recombination was performed by using the sucAB gene of Enterobacter agglomerans obtained as described above to obtain an ⁇ KGDH deficient strain of Enterobacter agglomerans.
  • pTWVEK101 was digested with Sph I to excise a fragment containing sucA , the fragment was blunt-ended with Klenow fragment (Takara Shuzo Co., Ltd.) and ligated with pBR322 digested with Eco RI and blunt-ended with Klenow fragment, by using T4 DNA ligase (Takara Shuzo Co., Ltd.).
  • the obtained plasmid was digested at the restriction enzyme Bgl II recognition site positioned substantially at the center of sucA by using this enzyme, blunt-ended with Klenow fragment, and then ligated again by using T4 DNA ligase. It was considered that the sucA gene did not function because a frameshift mutation was introduced into sucA of the plasmid newly constructed through the above procedure.
  • the plasmid constructed as described above was digested with a restriction enzyme Apa LI, and subjected to agarose gel electrophoresis to recover a DNA fragment containing sucA into which the frameshift mutation was introduced and a tetracycline resistance gene derived from pBR322.
  • the recovered DNA fragment was ligated again by using T4 DNA ligase to construct a plasmid for disrupting the ⁇ KGDH gene.
  • the plasmid for disrupting the ⁇ KGDH gene obtained as described above was used to transform the Enterobacter agglomerans SC17 strain by electroporation (Miller, J.H., A Short Course in Bacterial Genetics; Handbook", p.279, Cold Spring Harbor Laboratory Press, U.S.A., 1992), and a strain wherein sucA on the chromosome was replaced with a mutant type one by homologous recombination of the plasmid was obtained by using the tetracycline resistance as an indicator. The obtained strain was designated as SC17sucA strain.
  • a plasmid having a gdhA gene derived from Escherichia coli , pBRGDH (Japanese Patent Application Laid-open No. 7-203980), was digested with Hind III and Sph I, the both ends were blunt-ended by the T4 DNA polymerase treatment, and then the DNA fragment having the gdhA gene was purified and recovered.
  • a plasmid having a gltA gene and a ppc gene derived from Escherichia coli , pMWCP (WO 97/08294), was digested with Xba I, and then the both ends were blunt-ended by using T4 DNA polymerase.
  • the plasmid pVIC40 Japanese Patent Application Laid-open No. 8-047397 having the replication origin of the broad host spectrum plasmid RSF1010 was digested with Not I, treated with T4 DNA polymerase and digested with Pst I.
  • pBR322 was digested with Eco T14I, treated with T4 DNA polymerase and digested with PstI. The both products were mixed and ligated by using T4 ligase to obtain a plasmid RSF-Tet having the replication origin of RSF1010 and a tetracycline resistance gene (Fig. 7).
  • pMWCPG was digested with Eco RI and Pst I, and a DNA fragment having the gltA gene, the ppc gene and the gdhA gene was purified and recovered.
  • RSF-Tet was similarly digested with Eco RI and Pst I, and a DNA fragment having the replication origin of RSF1010 was purified and recovered.
  • the both products were mixed and ligated by using T4 ligase to obtain a plasmid RSFCPG, which corresponded to RSF-Tet containing the gltA gene, the ppc gene and the gdhA gene (Fig. 8).
  • the obtained plasmid RSFCPG expressed the gltA gene, the ppc gene and the gdhA gene, by the complementation of the auxotrophy of the gltA , ppc or gdhA gene deficient strain derived from Escherichia coli and measurement of each enzyme activity.
  • a plasmid having the gltA gene derived from Brevibacterium lactofermentum was constructed as follows. PCR was performed by using the primer DNAs having the nucleotide sequences represented by SEQ ID NOS: 6 and 7, which were prepared based on the nucleotide sequence of the Corynebacterium glutamicum gltA gene (Microbiology, 140, pp.1817-1828 (1994)), and chromosomal DNA of Brevibacterium lactofermentum ATCC13869 as a template to obtain a gltA gene fragment of about 3 kb. This fragment inserted into a plasmid pHSG399 (purchased from Takara Shuzo Co.
  • pHSGCB pHSGCB was digested with Hind III, and the excised gltA gene fragment of about 3 kb was inserted into a plasmid pSTV29 (purchased from Takara Shuzo Co., Ltd.) digested with HindIII to obtain a plasmid pSTVCB (Fig. 9). It was confirmed that the obtained plasmid pSTVCB expressed the gltA gene, by measuring the enzyme activity in the Enterobacter agglomerans AJ13355 strain.
  • the Enterobacter agglomerans SC17sucA strain was transformed with RSFCPG by electroporation to obtain a transformant SC17sucA/RSFCPG strain having tetracycline resistance. Further, the SC17sucA/RSFCPG strain was transformed with pSTVCB by electroporation to obtain a transformant SC17sucA/RSFCPG+pSTVCB strain having chloramphenicol resistance.
  • a strain with improved resistance to L-glutamic acid at a high concentration in a low pH environment (hereafter, also referred to as "high-concentration Glu-resistant strain at low pH") was isolated from the Enterobacter agglomerans SC17sucA/RSFCPG+pSTVCB strain.
  • the SC17sucA/RSFCPG+pSTVCB strain was cultured overnight at 30°C in LBG medium (10 g/L of tryptone, 5 g/L of yeast extract, 10 g/L of NaCl, 5 g/L of glucose), and the cells washed with saline was appropriately diluted and plated on an M9-E medium (4 g/L of glucose, 17 g/L of Na 2 HPO 4 ⁇ 12H 2 O, 3 g/L of KH 2 PO 4 , 0.5 g/L of NaCl, 1 g/L of NH 4 Cl, 10 mM of MgSO 4 , 10 ⁇ M of CaCl 2 , 50 mg/L of L-lysine, 50 mg/L of L-methionine, 50 mg/L of DL-diaminopimelic acid, 25 mg/L of tetracycline, 25 mg/L of chloramphenicol, 30 g/L of L-glutamic acid, adjusted to pH
  • L-glutamic acid-producing ability was tested in a 50-ml volume large test tube containing 5 ml of L-glutamic acid production test medium (40 g/L of glucose, 20 g/L of (NH 4 ) 2 SO 4 , 0.5 g/L of MgSO 4 ⁇ 7H 2 O, 2 g/L of KH 2 PO 4 , 0.5 g/L of NaCl, 0.25 g/L of CaCl 2 ⁇ 7H 2 O, 0.02 g/L of FeSO 4 ⁇ 7H 2 O, 0.02 g/L of MnSO 4 ⁇ 4H 2 O, 0.72 mg/L of ZnSO 4 ⁇ 2H 2 O, 0.64 mg/L of CuSO 4 ⁇ 5H 2 O, 0.72 mg/L of CoCl 2 ⁇ 6H 2 O, 0.4 mg/L of boric acid, 1.2 mg/L of Na 2 MoO 4 ⁇ 2H 2 O, 2 g/L of KH 2 PO 4 , 0.5 g/
  • the AJ13601 strain was deposited at the National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry (postal code: 305-8566, 1-3, Higashi 1-chome, Tsukuba-shi, Ibaraki, Japan) on August 18, 1999 and received an accession number of FERM P-17516. It was then transferred to an international deposition under the provisions of Budapest Treaty on July 6, 2000 and received an accession number of FERM BP-7207.
  • the Enterobacter agglomerans AJ13601 strain was inoculated into a 1-L jar fermenter containing 300 ml of medium containing 40 g/L of glucose, 20 g/L of (NH 4 ) 2 SO 4 , 0.5 g/L of MgSO 4 ⁇ 7H 2 O, 2 g/L of KH 2 PO 4 , 0.5 g/L of NaCl, 0.25 g/L of CaCl 2 ⁇ 7H 2 O, 0.02 g/L of FesO 4 ⁇ 7H 2 O, 0.02 g/L of MnSO 4 ⁇ 4H 2 O, 0.72 mg/L of ZnSO 4 ⁇ 2H 2 O, 0.64 mg/L of CuSO 4 ⁇ 5H 2 O, 0.72 mg/L of CoCl 2 ⁇ 6H 2 O, 0.4 mg/L of boric acid, 1.2 mg/L of Na 2 MoO 4 ⁇ 2H 2 O, 2 g/L of yeast extract, 200 mg/L of L-lys
  • the culture obtained as described above was centrifuged at 5000 rpm for 10 minutes, and the collected cells were inoculated into a 1-L jar fermenter containing 300 ml of medium containing 40 g/L of glucose, 5 g/L of (NH 4 ) 2 SO 4 , 1.5 g/L of MgSO 4 ⁇ 7H 2 O, 6 g/L of KH 2 PO 4 , 1.5 g/L of NaCl, 0.75 g/L of CaCl 2 ⁇ 7H 2 O, 0.06 g/L of FeSO 4 ⁇ 7H 2 O, 0.06 g/L of MnSO 4 ⁇ 4H 2 O, 2.16 mg/L of ZnSO 4 ⁇ 2H 2 O, 1.92 mg/L of CuSO 4 ⁇ 5H 2 O, 2.16 mg/L of CoCl 2 ⁇ 6H 2 O, 1.2 mg/L of boric acid, 3.6 mg/L of Na 2 MoO 4 ⁇ 2H 2 O, 6 g/L of yeast extract, 600
  • Table 1 shows the concentration of L-glutamic acid dissolved in the culture broth at that time and the L-glutamic acid concentration measured by dissolving the crystals in 2 M potassium hydroxide.
  • L-Glutamic acid crystals were collected from the culture by decantation after the culture was left stood.
  • Table 1 Concentration of L-glutamic acid dissolved in culture broth 51 g/L Amount of L-glutamic acid precipitated as crystals 67 g/L Concentration of L-glutamic acid measured by dissolving crystals 118 g/L
  • the Enterobacter agglomerans AJ13601 strain was inoculated into a 1-L jar fermenter containing 300 ml of medium containing 40 g/L of glucose, 20 g/L of (NH 4 ) 2 SO 4 , 0.5 g/L of MgSO 4 ⁇ 7H 2 O, 2 g/L of KH 2 PO 4 , 0.5 g/L of NaCl, 0.25 g/L of CaCl 2 ⁇ 7H 2 O, 0.02 g/L of FeSO 4 ⁇ 7H 2 O, 0.02 g/L of MnSO 4 ⁇ H 2 O, 0.72 mg/L of ZnSO 4 ⁇ 2H 2 O, 0.64 mg/L of CuSO 4 ⁇ 5H 2 O, 0.72 mg/L of CoCl 2 ⁇ 6H 2 O, 0.4 mg/L of boric acid, 1.2 mg/L of Na 2 MoO 4 ⁇ 2H 2 O, 2 g/L of yeast extract, 200 mg/L of L-lysine hydro
  • the culture pH was controlled by bubbling the medium with ammonia gas.
  • the culture obtained as described above was centrifuged at 5000 rpm for 10 minutes, and then the collected cells were cultured in a medium where L-glutamic acid was present as crystals.
  • the used medium contained 40 g/L of glucose, 5 g/L of (NH 4 ) 2 SO 4 , 1.5 g/L of MgSO 4 ⁇ 7H 2 O, 6 g/L of KH 2 PO 4 , 1.5 g/L of NaCl, 0.75 g/L of CaCl 2 ⁇ 7H 2 O, 0.06 g/L of FeSO 4 ⁇ 7H 2 O, 0.06 g/L of MnSO 4 ⁇ 4H 2 O, 2.16 mg/L of ZnSO 4 ⁇ 2H 2 O, 1.92 mg/L of CuSO 4 ⁇ 5H 2 O, 2.16 mg/L of CoCl 2 ⁇ 6H 2 O, 1.2 mg/L of boric acid, 3.6 mg/L of Na
  • the cells were inoculated in a 1-L jar fermenter containing 300 ml of this medium and cultured at 34°C and pH 4.3 to perform culture for L-glutamic acid production.
  • the culture pH was controlled by introducing ammonia gas into the medium. As the initially added glucose was depleted, 600 g/L of glucose was continuously added. In this medium, only 39 g/L of the added L-glutamic acid was dissolved at pH 4.3 and the remaining 1 g/L was present as crystals.
  • the Enterobacter agglomerans AJ13601 strain can grow not only at an acidic pH, but also at a neutral pH. Therefore, it was confirmed as follows that L-glutamic acid crystals could also be precipitated by starting the culture at a neutral pH and allowing production of L-glutamic acid during the culture so that pH of the culture should spontaneously be lowered.
  • LBG agar medium (10 g/ of L tryptone, 5 g/L of yeast extract, 10 g/L of NaCl, 5 g/L of glucose, 15 g/L of agar) containing 25 mg/L of tetracycline hydrochloride and 25 mg/L of chloramphenicol at 30°C for 14 hours, were inoculated into a 1-L jar fermenter containing 300 ml of medium containing 40 g/L of glucose, 5 g/L of (NH 4 ) 2 SO 4 , 1.5 g/L of MgSO 4 ⁇ 7H 2 O, 6 g/L of KH 2 PO 4 , 1.5 g/L of NaCl, 0.75 g/L of CaCl 2 ⁇ 7H 2 O, 0.06 g/L of FeSO 4 ⁇ 7H 2 O, 0.06 g/L of MnSO 4 ⁇

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP00117807A 1999-08-20 2000-08-18 Method for producing L-glutamic acid by fermentation accompanied by precipitation Expired - Lifetime EP1078989B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP23480699 1999-08-20
JP23480699 1999-08-20
JP2000078771 2000-03-21
JP2000078771 2000-03-21

Publications (4)

Publication Number Publication Date
EP1078989A2 EP1078989A2 (en) 2001-02-28
EP1078989A8 EP1078989A8 (en) 2001-04-25
EP1078989A3 EP1078989A3 (en) 2001-10-10
EP1078989B1 true EP1078989B1 (en) 2006-08-02

Family

ID=26531768

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00117807A Expired - Lifetime EP1078989B1 (en) 1999-08-20 2000-08-18 Method for producing L-glutamic acid by fermentation accompanied by precipitation

Country Status (16)

Country Link
US (5) US7015010B1 (es)
EP (1) EP1078989B1 (es)
JP (1) JP4427878B2 (es)
KR (4) KR100799469B1 (es)
CN (2) CN101230366B (es)
AT (1) ATE335081T1 (es)
AU (1) AU5345200A (es)
BR (1) BR0003695B1 (es)
DE (1) DE60029701T8 (es)
ES (1) ES2269047T3 (es)
ID (1) ID26915A (es)
MY (1) MY129239A (es)
PE (1) PE20010518A1 (es)
PL (1) PL341974A1 (es)
RU (1) RU2261272C2 (es)
TW (2) TW200427836A (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2559754A2 (en) 2011-08-18 2013-02-20 Ajinomoto Co., Inc. Method for producing an L-amino acid using a bacterium of the family enterobacteriaceae having enhanced expression of the flagella formation and motility cascade genes

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU756507B2 (en) 1998-03-18 2003-01-16 Ajinomoto Co., Inc. L-glutamic acid-producing bacterium and method for producing L-glutamic acid
JP4427878B2 (ja) 1999-08-20 2010-03-10 味の素株式会社 析出を伴う発酵法によるｌ−グルタミン酸の製造法
JP4560998B2 (ja) * 2001-02-05 2010-10-13 味の素株式会社 発酵法によるｌ−グルタミンの製造法及びｌ−グルタミン生産菌
JP4599726B2 (ja) * 2001-02-20 2010-12-15 味の素株式会社 Ｌ−グルタミン酸の製造法
JP4599725B2 (ja) * 2001-02-20 2010-12-15 味の素株式会社 Ｌ−グルタミン酸の製造法
JP4292724B2 (ja) 2001-02-20 2009-07-08 味の素株式会社 有機態窒素含有組成物及びそれを含む肥料
JP2002238592A (ja) 2001-02-20 2002-08-27 Ajinomoto Co Inc Ｌ−グルタミン酸の製造法
ES2736165T3 (es) * 2001-08-23 2019-12-26 Rsr Ltd Regiones epítopo de un receptor de tirotropina (TSH), sus usos y anticuerpos para las mismas
JP3932945B2 (ja) 2002-03-27 2007-06-20 味の素株式会社 Ｌ−アミノ酸の製造法
CN100383252C (zh) * 2003-05-07 2008-04-23 味之素株式会社 生产l-谷氨酸的方法
CN100510092C (zh) 2003-06-10 2009-07-08 味之素株式会社 生产l-谷氨酸的方法
US7344874B2 (en) 2004-03-04 2008-03-18 Ajinomoto Co., Inc. L-glutamic acid-producing microorganism and a method for producing L-glutamic acid
JP2008029202A (ja) * 2004-11-09 2008-02-14 Ajinomoto Co Inc Ｌ−グルタミン酸の製造法
RU2004137719A (ru) 2004-12-23 2006-06-10 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО АГРИ) (RU) Способ получения l-аминокислот с использованием бактерий семейства enterobacteriaceae
JP4734959B2 (ja) * 2005-02-25 2011-07-27 味の素株式会社 腸内細菌科に属する微生物内で自律複製可能な新規プラスミド
US7501282B2 (en) 2005-02-25 2009-03-10 Ajinomoto Co., Inc. Plasmid autonomously replicable in Enterobacteriaceae family
JP2009118740A (ja) 2006-03-03 2009-06-04 Ajinomoto Co Inc Ｌ−アミノ酸の製造法
WO2007119574A2 (en) 2006-03-23 2007-10-25 Ajinomoto Co., Inc. A method for producing an l-amino acid using bacterium of the enterobacteriaceae family with attenuated expression of a gene coding for small rna
EP2007873B1 (en) 2006-04-18 2015-11-18 Ajinomoto Co., Inc. A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY WITH ATTENUATED EXPRESSION OF THE sfmACDFH-fimZ CLUSTER OR THE fimZ GENE
JP2009165355A (ja) 2006-04-28 2009-07-30 Ajinomoto Co Inc Ｌ−アミノ酸を生産する微生物及びｌ−アミノ酸の製造法
JP2010017082A (ja) 2006-10-10 2010-01-28 Ajinomoto Co Inc Ｌ−アミノ酸の製造法
RU2006143864A (ru) 2006-12-12 2008-06-20 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО АГРИ) (RU) СПОСОБ ПОЛУЧЕНИЯ L-АМИНОКИСЛОТ С ИСПОЛЬЗОВАНИЕМ БАКТЕРИИ СЕМЕЙСТВА ENTEROBACTERIACEAE, В КОТОРОЙ ОСЛАБЛЕНА ЭКСПРЕССИЯ ГЕНОВ cynT, cynS, cynX, ИЛИ cynR, ИЛИ ИХ КОМБИНАЦИИ
JP2010041920A (ja) 2006-12-19 2010-02-25 Ajinomoto Co Inc Ｌ−アミノ酸の製造法
CN101627110B (zh) 2007-01-22 2014-08-13 味之素株式会社 生产l-氨基酸的微生物和l-氨基酸的生产方法
JP2010110216A (ja) * 2007-02-20 2010-05-20 Ajinomoto Co Inc Ｌ−アミノ酸または核酸の製造方法
JP2010110217A (ja) 2007-02-22 2010-05-20 Ajinomoto Co Inc Ｌ−アミノ酸生産菌及びｌ−アミノ酸の製造法
JP2010130899A (ja) 2007-03-14 2010-06-17 Ajinomoto Co Inc Ｌ−グルタミン酸系アミノ酸生産微生物及びアミノ酸の製造法
WO2008133161A1 (ja) 2007-04-17 2008-11-06 Ajinomoto Co., Inc. カルボキシル基を有する酸性物質の製造法
JP2011067095A (ja) 2008-01-10 2011-04-07 Ajinomoto Co Inc 発酵法による目的物質の製造法
EP2248906A4 (en) 2008-01-23 2012-07-11 Ajinomoto Kk PROCESS FOR THE PREPARATION OF L-AMINO ACID
RU2008105793A (ru) 2008-02-19 2009-08-27 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО АГРИ) (RU) Способ конструирования оперонов, содержащих трансляционно сопряженные гены, бактерия, содержащая такой оперон, способ продукции полезного метаболита и способ мониторинга экспрессии гена
EP2343371B1 (en) 2008-09-05 2015-10-21 Ajinomoto Co., Inc. Method for producing l-amino acid
EP2336347B1 (en) 2008-09-08 2017-03-15 Ajinomoto Co., Inc. An l-amino acid-producing microorganism and a method for producing an l-amino acid
CN102203274B (zh) * 2008-10-29 2017-04-05 株式会社钟化 L‑氨基酸的制造方法
BRPI1007069A2 (pt) 2009-01-23 2015-08-25 Ajinomoto Kk Método para produzir um l-aminoácido.
JPWO2011013707A1 (ja) 2009-07-29 2013-01-10 味の素株式会社 Ｌ−アミノ酸の製造法
JP2012223091A (ja) 2009-08-25 2012-11-15 Ajinomoto Co Inc Ｌ−アミノ酸の製造法
RU2460793C2 (ru) 2010-01-15 2012-09-10 Закрытое акционерное общество "Научно-исследовательский институт "Аджиномото-Генетика" (ЗАО АГРИ) Способ получения l-аминокислот с использованием бактерий семейства enterobacteriaceae
JP2013074795A (ja) 2010-02-08 2013-04-25 Ajinomoto Co Inc 変異型ｒｐｓＡ遺伝子及びＬ−アミノ酸の製造法
RU2471868C2 (ru) 2010-02-18 2013-01-10 Закрытое акционерное общество "Научно-исследовательский институт "Аджиномото-Генетика" (ЗАО АГРИ) Мутантная аденилатциклаза, днк, кодирующая ее, бактерия семейства enterobacteriaceae, содержащая указанную днк, и способ получения l-аминокислот
RU2482188C2 (ru) 2010-07-21 2013-05-20 Закрытое акционерное общество "Научно-исследовательский институт "Аджиномото-Генетика" (ЗАО АГРИ) СПОСОБ ПОЛУЧЕНИЯ L-АРГИНИНА С ИСПОЛЬЗОВАНИЕМ БАКТЕРИЙ РОДА Escherichia, В КОТОРОЙ ИНАКТИВИРОВАН ОПЕРОН astCADBE
RU2501858C2 (ru) 2010-07-21 2013-12-20 Закрытое акционерное общество "Научно-исследовательский институт "Аджиномото-Генетика" (ЗАО АГРИ) СПОСОБ ПОЛУЧЕНИЯ L-АМИНОКИСЛОТЫ С ИСПОЛЬЗОВАНИЕМ БАКТЕРИИ СЕМЕЙСТВА Enterobacteriaceae
JP2014036576A (ja) 2010-12-10 2014-02-27 Ajinomoto Co Inc Ｌ−アミノ酸の製造法
RU2496867C2 (ru) 2011-04-25 2013-10-27 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО "АГРИ") Способ получения l-аминокислоты семейства глутамата с использованием коринеформной бактерии
CN103703122B (zh) 2011-07-29 2019-04-26 三井化学株式会社 导入了二氧化碳的固定循环的微生物
CN103930557A (zh) 2011-11-11 2014-07-16 味之素株式会社 利用发酵法制造目标物质的方法
CN102703537B (zh) * 2012-06-26 2013-08-07 呼伦贝尔东北阜丰生物科技有限公司 一种新的谷氨酸生产方法
MY174741A (en) 2013-01-24 2020-05-13 Mitsui Chemicals Inc Microorganism for production of chemicals derived from acetyl-coa
KR101714943B1 (ko) 2013-01-24 2017-03-09 미쓰이 가가쿠 가부시키가이샤 이산화탄소 고정 회로를 도입한 미생물
RU2013118637A (ru) 2013-04-23 2014-10-27 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО "АГРИ") СПОСОБ ПОЛУЧЕНИЯ L-АМИНОКИСЛОТ С ИСПОЛЬЗОВАНИЕМ БАКТЕРИИ СЕМЕЙСТВА ENTEROBACTERIACEAE, В КОТОРОЙ РАЗРЕГУЛИРОВАН ГЕН yjjK
PE20150681A1 (es) 2013-05-13 2015-05-15 Ajinomoto Kk Metodo para producir l-aminoacidos
JP2016165225A (ja) 2013-07-09 2016-09-15 味の素株式会社 有用物質の製造方法
RU2013140115A (ru) 2013-08-30 2015-03-10 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО "АГРИ") СПОСОБ ПОЛУЧЕНИЯ L-АМИНОКИСЛОТ С ИСПОЛЬЗОВАНИЕМ БАКТЕРИИ СЕМЕЙСТВА Enterobacteriaceae, В КОТОРОЙ НАРУШЕНА ЭКСПРЕССИЯ КЛАСТЕРА ГЕНОВ znuACB
JP2016192903A (ja) 2013-09-17 2016-11-17 味の素株式会社 海藻由来バイオマスからのｌ−アミノ酸の製造方法
JP5958653B2 (ja) 2013-10-02 2016-08-02 味の素株式会社 アンモニア制御装置およびアンモニア制御方法
RU2013144250A (ru) 2013-10-02 2015-04-10 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО "АГРИ") СПОСОБ ПОЛУЧЕНИЯ L-АМИНОКИСЛОТ С ИСПОЛЬЗОВАНИЕМ БАКТЕРИИ СЕМЕЙСТВА Enterobacteriaceae, В КОТОРОЙ ОСЛАБЛЕНА ЭКСПРЕССИЯ ГЕНА, КОДИРУЮЩЕГО ФОСФАТНЫЙ ТРАНСПОРТЕР
JP6459962B2 (ja) 2013-10-21 2019-01-30 味の素株式会社 Ｌ−アミノ酸の製造法
JP6519476B2 (ja) 2013-10-23 2019-05-29 味の素株式会社 目的物質の製造法
RU2014105547A (ru) 2014-02-14 2015-08-20 Адзиномото Ко., Инк. СПОСОБ ПОЛУЧЕНИЯ L-АМИНОКИСЛОТ С ИСПОЛЬЗОВАНИЕМ БАКТЕРИИ СЕМЕЙСТВА ENTEROBACTERIACEAE, ИМЕЮЩЕЙ СВЕРХЭКСПРЕССИРУЕМЫЙ ГЕН yajL
CN103937842B (zh) * 2014-04-11 2017-01-18 江南大学 一种提高全细胞转化生产α‑酮戊二酸产量的方法
RU2015120052A (ru) 2015-05-28 2016-12-20 Аджиномото Ко., Инк. Способ получения L-аминокислоты с использованием бактерии семейства Enterobacteriaceae, в которой ослаблена экспрессия гена gshA
JP6623690B2 (ja) 2015-10-30 2019-12-25 味の素株式会社 グルタミン酸系ｌ−アミノ酸の製造法
BR112018017227A2 (pt) 2016-02-25 2019-02-05 Ajinomoto Kk método para produzir um l-aminoácido
JP7066977B2 (ja) 2017-04-03 2022-05-16 味の素株式会社 Ｌ－アミノ酸の製造法
WO2020071538A1 (en) 2018-10-05 2020-04-09 Ajinomoto Co., Inc. Method for producing target substance by bacterial fermentation
CN109628513B (zh) * 2018-12-19 2022-01-04 呼伦贝尔东北阜丰生物科技有限公司 一种氨基酸发酵培养基及其制备方法
BR112021014194A2 (pt) 2019-02-22 2021-12-28 Ajinomoto Kk Método para a produção de um l-aminoácido
BR112021017870A2 (pt) 2019-04-05 2021-12-07 Ajinomoto Kk Método para produzir um l-aminoácido
JP2022550084A (ja) 2019-09-25 2022-11-30 味の素株式会社 細菌の発酵によるｌ－アミノ酸の製造方法
CN111254169B (zh) * 2019-12-30 2023-05-12 广州舒国生物科技有限公司 大肠杆菌cf16在产谷氨酸或谷氨酸钠中的应用
JPWO2022092018A1 (es) 2020-10-28 2022-05-05
US20240117393A1 (en) 2022-09-30 2024-04-11 Ajinomoto Co., Inc. Method for producing l-amino acid
CN117000756B (zh) * 2023-06-27 2024-07-19 广东省科学院生态环境与土壤研究所 一种微生物-矿物复合菌剂及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62288A (ja) * 1985-03-09 1987-01-06 Sanraku Inc 発酵法によるｌ−アミノ酸の製造方法
JPH119296A (ja) * 1997-06-27 1999-01-19 Ajinomoto Co Inc 発酵法によるｌ−グルタミン酸の製造法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL236891A (es) 1958-03-07
US3220929A (en) 1964-02-10 1965-11-30 Kyowa Hakko Kogyo Kk Microbiological production of amino acid by reductive amination
JP3528205B2 (ja) * 1993-07-30 2004-05-17 味の素株式会社 Ｌ−３，４−ジヒドロキシフェニルアラニンの製造方法
JP3880636B2 (ja) * 1994-01-10 2007-02-14 味の素株式会社 発酵法によるｌ−グルタミン酸の製造法
ES2191710T3 (es) * 1994-08-19 2003-09-16 Ajinomoto Kk Procedimiento para producir l-lisina y acido l-glutamico por fermentacion.
WO1997008294A1 (fr) 1995-08-23 1997-03-06 Ajinomoto Co., Inc. Procede de production d'acide l-glutamique par fermentation
JPH09285294A (ja) 1996-04-23 1997-11-04 Ajinomoto Co Inc 発酵法によるｌ−グルタミン酸の製造法
AU746542B2 (en) * 1998-03-18 2002-05-02 Ajinomoto Co., Inc. L-glutamic acid-producing bacterium and method for producing L-glutamic acid
AU756507B2 (en) * 1998-03-18 2003-01-16 Ajinomoto Co., Inc. L-glutamic acid-producing bacterium and method for producing L-glutamic acid
US7247459B1 (en) * 1998-10-19 2007-07-24 Ajinomoto Co., Inc. L-glutamic acid producing bacterium and process for producing L-glutamic acid
JP4427878B2 (ja) * 1999-08-20 2010-03-10 味の素株式会社 析出を伴う発酵法によるｌ−グルタミン酸の製造法
TW200734459A (en) 1999-10-04 2007-09-16 Ajinomoto Kk Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria
JP4304837B2 (ja) * 2000-07-05 2009-07-29 味の素株式会社 Ｌ−グルタミン酸生産菌及びｌ−グルタミン酸の製造法
JP4560998B2 (ja) * 2001-02-05 2010-10-13 味の素株式会社 発酵法によるｌ−グルタミンの製造法及びｌ−グルタミン生産菌
JP4599726B2 (ja) 2001-02-20 2010-12-15 味の素株式会社 Ｌ−グルタミン酸の製造法
JP4292724B2 (ja) 2001-02-20 2009-07-08 味の素株式会社 有機態窒素含有組成物及びそれを含む肥料
JP4599725B2 (ja) * 2001-02-20 2010-12-15 味の素株式会社 Ｌ−グルタミン酸の製造法
JP2002238592A (ja) 2001-02-20 2002-08-27 Ajinomoto Co Inc Ｌ−グルタミン酸の製造法
RU2230114C2 (ru) 2001-11-30 2004-06-10 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" Мутантная глутаминсинтетаза, фрагмент днк, штамм escherichia coli - продуцент l-глутамина и способ получения l-аминокислот
JP3932945B2 (ja) 2002-03-27 2007-06-20 味の素株式会社 Ｌ−アミノ酸の製造法
AU2003205041A1 (en) 2002-07-12 2004-01-29 Ajinomoto Co., Inc. Method for producing target substance by fermentation
CN100383252C (zh) 2003-05-07 2008-04-23 味之素株式会社 生产l-谷氨酸的方法
CN100510092C (zh) 2003-06-10 2009-07-08 味之素株式会社 生产l-谷氨酸的方法
PL1664318T3 (pl) 2004-01-30 2010-03-31 Ajinomoto Kk Mikroorganizm wytwarzający L-aminokwas i sposób wytwarzania L-aminokwasu
US7344874B2 (en) 2004-03-04 2008-03-18 Ajinomoto Co., Inc. L-glutamic acid-producing microorganism and a method for producing L-glutamic acid
RU2004124226A (ru) 2004-08-10 2006-01-27 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО АГРИ) (RU) Использование фосфокетолазы для продукции полезных метаболитов
US7205132B2 (en) 2004-09-10 2007-04-17 Ajinomoto Co., Inc. L-glutamic acid-producing microorganism and a method for producing L-glutamic acid
US7794989B2 (en) 2004-12-28 2010-09-14 Ajinomoto Co., Inc. L-glutamic acid-producing microorganism and a method for producing L-glutamic acid
US7547531B2 (en) 2005-01-18 2009-06-16 Ajinomoto Co., Inc. L-amino acid producing microorganism which has been modified to inactive the fimH gene, and a method for producing I-amino acid
US7501282B2 (en) 2005-02-25 2009-03-10 Ajinomoto Co., Inc. Plasmid autonomously replicable in Enterobacteriaceae family
JP5011675B2 (ja) 2005-08-09 2012-08-29 味の素株式会社 物質の生産プロセスのシミュレーション方法
KR101078611B1 (ko) 2005-08-26 2011-11-01 아지노모토 가부시키가이샤 Ｌ-글루탐산 생산균 및 ｌ-글루탐산의 제조방법
JP2007117082A (ja) 2005-09-27 2007-05-17 Ajinomoto Co Inc Ｌ−アミノ酸生産菌及びｌ−アミノ酸の製造法
EP2054500B1 (en) 2006-08-18 2016-11-23 Ajinomoto Co., Inc. An l-glutamic acid producing bacterium and a method for producing l-glutamic acid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62288A (ja) * 1985-03-09 1987-01-06 Sanraku Inc 発酵法によるｌ−アミノ酸の製造方法
JPH119296A (ja) * 1997-06-27 1999-01-19 Ajinomoto Co Inc 発酵法によるｌ−グルタミン酸の製造法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Derwent World Patents Index; AJINOMOTO KK: "Manufacturing L-glutamic acid by fermentation for foodstuff, pharmaceutical - comprises culturing Corynebacterium striatam in culture media" *
DATABASE WPI Derwent World Patents Index; SANRAKU OCEAN CO LTD: "L-amino acid prodn. by fermentation method - involves continuing fermentation whilst crystallising L-aminoacid stored in culture soln." *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2559754A2 (en) 2011-08-18 2013-02-20 Ajinomoto Co., Inc. Method for producing an L-amino acid using a bacterium of the family enterobacteriaceae having enhanced expression of the flagella formation and motility cascade genes
WO2013024904A1 (en) 2011-08-18 2013-02-21 Ajinomoto Co.,Inc. A method for producing an l-amino acid using a bacterium of the family enterobacteriaceae having enhanced expression of the flagella formation and motility cascade genes

Also Published As

Publication number Publication date
KR20010050133A (ko) 2001-06-15
BR0003695B1 (pt) 2011-08-23
KR20080083103A (ko) 2008-09-16
TW200427836A (en) 2004-12-16
EP1078989A2 (en) 2001-02-28
CN100379871C (zh) 2008-04-09
ATE335081T1 (de) 2006-08-15
PE20010518A1 (es) 2001-05-10
US20050227334A1 (en) 2005-10-13
KR100866479B1 (ko) 2008-11-11
CN1292421A (zh) 2001-04-25
RU2261272C2 (ru) 2005-09-27
TWI250211B (en) 2006-03-01
US20070134773A1 (en) 2007-06-14
CN101230366A (zh) 2008-07-30
DE60029701T2 (de) 2007-08-09
KR20070106959A (ko) 2007-11-06
EP1078989A3 (en) 2001-10-10
DE60029701D1 (de) 2006-09-14
US7015010B1 (en) 2006-03-21
KR100799469B1 (ko) 2008-01-30
JP4427878B2 (ja) 2010-03-10
CN101230366B (zh) 2011-09-07
AU5345200A (en) 2001-02-22
EP1078989A8 (en) 2001-04-25
ES2269047T3 (es) 2007-04-01
US20090162907A1 (en) 2009-06-25
JP2001333769A (ja) 2001-12-04
PL341974A1 (en) 2001-02-26
ID26915A (id) 2001-02-22
USRE42350E1 (en) 2011-05-10
US7208296B2 (en) 2007-04-24
BR0003695A (pt) 2001-06-05
MY129239A (en) 2007-03-30
KR20090127855A (ko) 2009-12-14
DE60029701T8 (de) 2008-01-03

Similar Documents

Publication Publication Date Title
EP1078989B1 (en) Method for producing L-glutamic acid by fermentation accompanied by precipitation
US6596517B2 (en) Method for producing L-glutamic acid
USRE41800E1 (en) Method for producing l-glutamic acid
EP0952221B1 (en) L-Glutamic acid-producing bacterium and method for producing L-glutamic acid
EP1233071B9 (en) Organic nitrogen-containing composition and fertilizer comprising the same
EP1233070B1 (en) Method for producing L-glutamic acid
AU2005200716B2 (en) Method for producing L-glutamic acid by fermentation accompanied by precipitation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: AJINOMOTO CO., INC.

RIN1 Information on inventor provided before grant (corrected)

Inventor name: IZUI, HIROSHI, C/O AJINOMOTO CO., INC.

Inventor name: ITO, HISAO, C/O AJINOMOTO CO., INC.

Inventor name: MORIYA, MIKA, C/O AJINOMOTO CO., INC.

Inventor name: HIRANO, SEIKO, C/O AJINOMOTO CO., INC.

Inventor name: MATSUI, KAZUHIKO C/O ZAO AGRI

Inventor name: HARA, YOSHIHIKO, C/O AJINOMOTO CO., INC.

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12N 15/53 A, 7C 12N 15/60 B, 7C 12N 1/21 B, 7C 12N 1/20 B, 7C 12P 13/14 B, 7C 12N 9/88 B, 7C 12N 9/06 B, 7C 12R 1/01 B, 7C 12N 1/20 J, 7C 12R 1:01 J, 7C 12R 1:425 J

17P Request for examination filed

Effective date: 20020322

AKX Designation fees paid

Free format text: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20040112

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060802

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060802

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060802

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060818

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060831

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 60029701

Country of ref document: DE

Date of ref document: 20060914

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061102

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061102

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: A. BRAUN, BRAUN, HERITIER, ESCHMANN AG PATENTANWAE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070102

ET Fr: translation filed
REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2269047

Country of ref document: ES

Kind code of ref document: T3

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20070503

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061103

REG Reference to a national code

Ref country code: CH

Ref legal event code: PFA

Owner name: AJINOMOTO CO., INC.

Free format text: AJINOMOTO CO., INC.#15-1, KYOBASHI 1-CHOME, CHUO-KU#TOKYO 104 (JP) -TRANSFER TO- AJINOMOTO CO., INC.#15-1, KYOBASHI 1-CHOME, CHUO-KU#TOKYO 104 (JP)

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060818

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060802

REG Reference to a national code

Ref country code: CH

Ref legal event code: PCAR

Free format text: NEW ADDRESS: HOLBEINSTRASSE 36-38, 4051 BASEL (CH)

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20140813

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20150827

Year of fee payment: 16

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20150818

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 17

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150818

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 18

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160818

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20190712

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20190806

Year of fee payment: 20

Ref country code: ES

Payment date: 20190903

Year of fee payment: 20

Ref country code: FR

Payment date: 20190711

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20190819

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 60029701

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MK

Effective date: 20200817

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20220110

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20200819